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During the last decade much work has been focused on the use of nanostructures toward 
problems of biology and medicine. The issue of nanostructures application in cancer 
therapy depends on the effectiveness of the nanocrystals loading into cells. In this work 
chiral nanostructures based on CdSe/ZnS quantum dots (QD) and CdSe/CdS quantum 
dots in quantum rods (DiR) solubilized by L- and D-cysteine were formed using phase 
transfer method.  We studied photophysical properties of chiral nanostructures in 
different biological media and analyzed spectral luminescent properties of complexes 
based on chiral nanostructures. Enantioselective cellular uptake of nanostructures was 
revealed, namely that L-cysteine capped nanocrystals uptake is higher than that of D-
cysteine capped nanocrystals. Enantioselective interaction between chiral enantiomers 
of molecules and chiral nanostructures was detected. We believe this principle may lay 
the groundwork for novel approaches to studying biological objects and to application 
of nanostructures in medicine. 
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Symbols and abbreviations 
Symbols 
  
C concentration  
d nanostructure core diameter 
D optical density 
Et  transfer efficiency 
I intensity (luminescence) 
kr energy transition radiative constant 
n  refractive index 
N = 6,022 ·1023 mol-1  Avogadro constant 
Nabs number of absorbed quanta 
Nemit number of emitted quanta 
QY0D  donor luminescence quantum yield without a quenching agent 
R0  distance between a donor and an acceptor at which the energy 
transfer efficiency by FRET mechanism is 50% 
RDA distance between a donor and an acceptor 
ε extinction coefficient 
λ wavelength 
𝜏  luminescence lifetime 
〈𝜏〉 mean luminescence lifetime 
φ  quantum yield 
Ф2 = 2 3⁄  orientation factor 
 
Abbreviations 
Ce6 chlorin e6 
DiR quantum dot in quantum rod 
EAC Ehrlich ascites carcinoma  
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FRET Förster resonance energy transfer 
NC nanocrystal 
QD quantum dots  
QR nanorod, quantum rod 
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1 Introduction 
 
Chirality is mainly related to symmetry of molecules. A lack of violation of 
symmetry is referred to as asymmetry.  Asymmetry can be found on different levels of 
matter. The objects are chiral, if they cannot be superposed with their mirror image. 
Chirality is a typical characteristic of most biologically active molecules, and is 
responsible for their stereo aspects when these molecules interact the surrounding 
medium. Chirality is also one of the key factors for molecular recognition that has many 
applications in chemistry and biology. 
Currently, huge research efforts have been focused on chirality research. 
Scientists have conducted experiments to modify the surfaces of nanostructures. Chiral 
nanostructures can be obtained by using chiral molecules as stabilizers in colloid 
synthesis or as ligands in post-synthesis phase transfer.  
There is a theory that these chiral properties of quantum dots may affect their 
ability of interacting with biomolecules. As we know the most important elements of 
living organisms, the amino acids and nucleic acids, possess chiral properties. So, 
chirality can modulate several vital processes in the living cells.  Chirality of 
nanostructures can also affect their uptake by biological objects, for example, cancer 
cells.  
CdSe/ZnS nanocrystals are often used in such studies because of their bright and 
stable photoluminescence. In this work chiral nanostructures based on CdSe/ZnS 
quantum dots (QDs) and CdSe/CdS quantum dots in quantum rods (DiRs) solubilized 
by L- and D-cysteine were formed using phase transfer method.  When studying chiral 
nanostructures, the most precise attention is given to their photophysical properties, 
because these properties play a key role for various potential applications, such as in 
disease diagnostics and treatment.  Another important issue is the complexes of 
nanostructures with tetrapyrrole molecules, which also possess chirality.  
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The goal of this work is formation of chiral nanostructures and investigation of 
their photophysical properties in different biological media, including the living cells of 
Ehrlich ascites carcinoma. 
The first chapter of this dissertation contains an analytical literature review 
dedicated to main properties of different nanostructures and complexes based on them, 
as well as their applications in biomedicine. 
The second chapter describes the materials, equipment and methods that were 
used for spectral-luminescent analysis of chiral nanostructures and complexes based on 
nanocrystals and photosensitizer molecules. 
 The third chapter is devoted to studying the optical properties of chiral 
semiconductor nanocrystals.  
In the fourth chapter, we study the problem of penetrating the living cells of 
Ehrlich ascites carcinoma by chiral nanostructures and estimate the influence of 
nanostructure chirality type on the efficiency of intracellular penetration.  
The fifth chapter is dedicated to studying photophysical properties of complexes 
formed by chiral nanostructures and tetrapyrrole compound molecules – chlorin e6.   
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2 Background 
2.1. Nanostructures 
 
Nanostructures are usually considered as particles less than 100 nm in dimension.  
This type of structures has been used in an increasing number of different applications, 
including drug delivery [1].  Another issue of increasing importance is application of 
fluorescent semiconductor nanocrystals (quantum dots (QDs), nanorods (QRs), 
quantum dots in quantum rods (DiRs), dendrimers) as objects that can be used in 
therapy, bioengineering and medical examination [2]. 
 
2.1.1. Types of nanostructures 
 
Today the processes of hierarchic self-organization play an important role in 
nanotechnology and photonics. Colloid nanoparticles stabilized by ligands are an 
excellent example of hierarchic order self-organization. The core of non-organic 
nanoparticle determines the properties of the formed structure; in turn the surface 
ligands define interaction of the structure with external medium [3]. Understanding 
these processes of interactions will lead to practical implementation of "bottom-up" 
nanotechnologies as an alternative to "top-down" type nanotechnologies 
(nanolithography, molecular beam epitaxy and others) [4]. 
Ligand-stabilized colloid nanoparticles, self-organized into one- two- or three-
dimensional nanostructures with unique optical, electronic and magnetic properties by 
electrostatic, Van-der-Waals and other forms of interaction, have been demonstrated 
very recently [5].  
Among different kinds of colloid nanostructures, the quantum dots (QD) are the 
most studied ones due to their simple fabrication, tunable light emission in visible and 
near infrared spectral regime, as well as a wide range of applications, from light 
12 
 
emitting diodes to biological marking [6,7,8].  Quantum dots normally belong to binary 
and doped semiconductor materials of groups II-VI, III-V and IV-VI with sizes of ~2-20 
nm in three dimensions.  
Controlled synthesis technology allows changing the nanoparticle form using 
nanocrystal anisotropy. Crystal structure characteristics of a particular material defines 
the direction of growth, which in turn affects the nanocrystal form [9,10]. This is how 
nanorods or tetrapods – nanocrystals stretched in four directions – are made.  A shell 
applied on the nanostructure core changes the crystal shape in a similar way. 
Particularly, nanostructures of "quantum dot in quantum rod" type (DiR) are fabricated 
in the process of rod-shaped shell growth over a spherical core [11]. 
   
2.1.2. Photophysical properties of nanostructures 
 
Semiconductor nanocrystals with sizes less than the exciton Bohr radius represent 
an intermediate class of materials between molecular and macroscopic forms of matter.  
In such nanocrystal an electron and a hole act as in a three-dimensional potential well; 
quantum confinement of both the electron and hole in all three dimensions leads to an 
increase of the effective band gap of the material, as the crystal size decreases [12].  
Similarly to transitions between energy levels in an atom, a photon can be emitted or 
absorbed during charge carrier transitions between energy levels in nanocrystals [13].  
Therefore, a decrease in quantum dot size leads to a blue spectral shift (to higher energy 
band). This process observed for both quantum dots optical absorption and emission. 
The transition frequencies, i.e. absorption or luminescence wavelengths, can be tuned 
by altering the nanocrystal size.  Apart from this, the nanocrystals possess unique 
optical properties, such as wide absorption spectrum, as well as relatively high 
extinction coefficients and photoluminescence quantum yields. 
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2.1.3. Synthesis of semiconductor colloid nanostructures  
 
Composite core/shell semiconductor nanostructures possess unique properties, 
making them promising from both fundamental and practical points of view.  Several 
examples of core/shell type nanostructures are CdSe/CdS and CdS/CdSe, CdS/ZnS, 
CdSe/ZnS, CdS/HgS/CdS, ZnSe/CdSe, Si/SiO2 [2-11]. 
The synthesis of core/shell CdSe/ZnS colloid nanocrystals is performed by 
pyrolysis method [10,11]. CdSe/ZnS QDs with diameters ranging from 23 to 55 Å are 
synthesized by pyrolysis of metal-organic compounds, such as dimethylcadmium 
(C2H6Cd) and trioctylphosphine selenide (ТОPSе) in a coordinating solvent 
trioctylphosphine oxide (TOPO); oleic acid can be used as a stabilizer [11].  Diethylzinc 
(ZnEt2) and bis(trimethylsilyl)sulfan ((ТМС)2S) are normally used as Zn and S 
precursors. In order to fabricate DiR nanostructures, directed shell growth is performed.  
CdSe QDs about 2-3 nm in diameter serve as seeds [11,15]. A schematic image of DiR 
nanostructure is shown on Figure 2.1. 
 
Figure 2.1. Schematic images of DiR core (red)/shell (pink) type nanostructures [11]. 
L – length; d – diameter. 
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2.2. Biological and medical applications of nanostructures 
 
Nanostructures have attracted growing interest for various applications, such as 
chemistry, biochemistry, pharmacology and medicine [16].   In 1998, Bruchez and a 
group of researchers for the first time have reported application of quantum dots in 
immunofluorescence for labeling actin filaments in mice fibroblasts [17]. Later, 
quantum dots have been used for identifying a wide spectrum of proteins due to their 
ability to bind to specific antibodies [18-20]. A concept image of a quantum dot is 
shown on Figure 2.2. Hydrophobic drugs can be embedded into the structure between a 
hydrophobic nanoparticle core and a layer of amphiphile polymer; hydrophilic 
molecules can be immobilized on the nanostructure surface for specific binding to 
therapeutic compounds. From the moment of the first reported application of quantum 
dots for biological objects visualization in 2001, the nanostructures are actively used in 
in vivo and in vitro studies [4,21]. 
 
Figure 2.2. Schematic image of a multifunctional quantum dot covered by amphiphile 
polymer [20]. 
Lately much efforts have been put into reducing the potential toxicity of 
nanostructures by developing new compositions, new shells and fabricating smaller 
nanostructures in order to simplify cellular uptake for cells [22-25].  Bio-conjugation 
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ability, i.e. specific binding of nanostructures to antibodies antibodies that 
predominantly bind surface antigens in cancer cells; as well as creation of complexes of 
nanostructure with drugs, have induced research efforts dedicated to using them in 
diagnostics and treatment of oncological diseases [24]. 
  
2.2.1. Nanoparticles as fluorescent markers 
 
Development of highly sensitive and specific probes that are more stable than 
organic dyes and fluorescent proteins is of great interest for many research areas, from 
molecular and cellular biology to molecular visualization and medical diagnostics 
[6,19,26] (Figure 2.3).  
 
Figure 2.3. Bioluminescent images of living mice with injected nanostructures [21]. The 
left-hand image shows QD-tagged cancer cells, the right-hand image shows QD-
encoded microbeads emitting green, yellow and red light. 
Two strategies are used for incorporating nanostructures into cells: active 
method,– by using specific binding between nanocrystals and the surface of cancer 
cells, and passive approach targeting the nanostructures to the cells without specific 
binding [21]. 
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2.2.2. Application of nanostructures in oncology 
 
In 2004 a new class of quantum dot conjugates was developed. It possessed both 
hydrophilic and hydrophobic properties. It also contained an amphiphile triblock 
copolymer (composed of three polymer blocks) for in vivo protection, targeting ligands 
for recognition of  cancerous tumor antigens and polyethylene glycol molecules (PEG) 
for improved biocompatibility and nanostructure circulation in the organism [21,27].  
Antibodies conjugated to a QD are used for active tumor targeting, ensuring binding to 
a specific membrane agent [25].   
In case of passive targeting, the macromolecules and nanoparticles accumulate in 
the tumor mostly due to enhanced permeation and retention [21]. It is believed that this 
effect arises from two factors: 
• Tumor angiogenic vascular endothelial growth factors produce 
hyperpermeable blood vessels, leading to leakage of circulating macromolecules and 
small particles; 
• Tumors lack an effective lymphatic drainage system, resulting in 
macromolecule or nanoparticle accumulation.   
Apart from this, it is important to consider the processes responsible for 
nanostructure accumulation not only in tumors, but also in normal tissues as well.  
According to research performed by Xiaohu Gao group in 2004 [21], passive uptake of 
quantum dots and their retention happens mostly in livers and spleens, while is almost 
not observed in brains, hearts, kidneys or lungs. 
  
2.2.3. Chiral nanostructures for biomedical applications 
 
Investigations are ongoing on extending the capabilities of nanostructures by 
modifying their surface. Very recently the Balaz group [28] studied the induced circular 
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dichroism in CdSe quantum dots. The researchers discovered that chiral thiol ligands, 
such as L- and D-cysteine may induce chiral properties in initially achiral quantum dots. 
For CdSe quantum dots capped by L- and D-cysteine a mirror image of signals in 
circular dichroism spectra is observed, as shown on Figure 2.4.  In this case the origin of 
induced circular dichroism in quantum dots is explained by hybridization of chiral 
ligand molecular orbitals with the valence band of quantum dot [29]. 
 
Figure 2.4. Spectra of induced circular dichroism (solid lines) of CdSe/ZnS 
quantum dots capped by L- and D-cysteine, dotted lines show absorption spectra 
[29] 
Chiral quantum dots can be obtained by using chiral molecules as stabilizers in 
colloid synthesis or as ligands in post-synthesis phase transfer [30]. A theory was 
proposed that these chiral properties of quantum dots may affect their ability of 
interacting with biomolecules, and therefore modulate several vital processes in the 
living cells, because the most important elements of living organisms, the amino acids 
and nucleic acids, possess chiral properties. 
Chiral compounds play a tremendous role in chemistry, pharmacology, biology 
and medicine.  Chirality is also one of the key factors for molecular recognition, that has 
many applications in chemistry and biology [31-33]. It is known that stereoisomers are 
mirror images of each other and cannot be superposed. Development of effective 
methods for preparation and identification of pure enantiomeric compounds, composed 
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of stereoisomers is crucial for developing pharmaceutical drugs, agrochemicals, 
flavorings and food additives [34,35]. 
 
2.2.4 Using nanostructures in photodynamic therapy 
 
Innovative technologies based on nanoparticles for fighting against oncological 
diseases and for improving already existing methods are currently being developed [36]. 
Photodynamic therapy (PDT) is one of the available cancer treatment methods, 
introduced into clinical practice about twenty years ago [36-38].  
PDT effect is based on using compounds with photoallergic properties which 
selectively accumulated in malignant tumors. Typically used light radiation, mostly in 
the red spectral region, where the tissues are transparent for the light[39].   The aim of 
this method is to induce cytotoxic effect on the cancerous tumor. The basic principles of 
photodynamic therapy are shown in Figure 2.5. A photosensitizer with insignificant 
toxicity is injected into the organism (Figure 2.5A), subsequently accumulates mostly in 
cancerous cells which divide more quickly (Figure 2.5B). Then, the photosensitizer is 
activated by optical radiation (Figure 2.5C) and induces toxic effect on the cells, leading 
to their perish (Figure 2.5D). 
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A 
 
B 
C D 
Figure 2.5. General principle of photodynamic therapy [40]  
The Jablonski diagram explaining the photodynamic therapy process is shown in 
Figure 2.6. Upon illumination, the photosensitizer (PS) is excited from the ground state 
(S0) to the first excited singlet state (S1) with subsequent conversion to the triplet state 
(T1) [41] (Figure 1.6). The excited triplet state may react in two ways, defined as type I 
and type II mechanisms. The type I mechanism involves a reaction between a sensitizer 
in the excited state and a biological substrate, which yields free radicals and radical ions 
capable of causing irreparable damage to biological objects [42]. The type II mechanism 
results from the energy transfer between the sensitizer in an excited triplet state and 
molecular oxygen at the ground state, generating a singlet state of oxygen (
1О2). This 
oxygen state can interact with a large number of biological cells, inducing oxidative 
damage and, ultimately, cell inactivation [42]. 
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Figure 2.6. The modified Jablonski diagram explaining the photodynamic therapy 
process. Abbreviations: IC: internal crossing, ISC: intersystem crossing, PS: 
photosensitizer; 1PS*: excited singlet state; T1: triplet excited state; R: biological 
substrate;  
R*: oxidized biological substrate; 
1
O2: singlet oxygen state; H2O2: hydrogen peroxide; 
O2
*
: active form of oxygen; HO
*
: hydroxyl radical [41]. 
Unique optical properties of quantum dots and their good stability led to an idea 
of using  the quantum-dot/photosensitizer complexes for cancer photodynamic therapy 
in 2003 [43] (Figure 2.7). 
 
Figure 2.7. Quantum dot/chlorin e6 (Ce6) photosensitizer complex in a lipid shell 
[44]. 
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Quantum dot/photosensitizer complexes can extend the photosensitizer excitation 
band and improve its efficiency. They may also solve the selectivity problem, therefore 
significantly increasing photosensitizer practicality.  Quantum nanostructures in 
complexes with photosensitizers are suitable photoexcitation energy donors in the 
process of Förster resonance energy transfer (FRET), and can therefore increase the 
efficiency of molecular excitation [43]. 
 
2.3. Nanostructure–photosensitizer complexes 
 
Nowadays many types of complexes of nanostructures and photosensitizer 
molecules for photodynamic therapy have been described [45,46,47], with their 
potential not yet fully uncovered.  Several recent research publications demonstrated 
complexes where FRET processes can operate with energy transfer efficiency close to 
the value theoretically predicted [45].  However, photophysics of quantum dots 
sensitized by molecules is rather complex, thus  unstudied and unexplained 
photoexcitation relaxation channels inside the complexes are observed. These processes 
lead to low intracomplex FRET efficiency [45-47]. 
 
2.3.1. Bonding mechanisms in complexes of nanocrystals and tetrapyrrole molecules 
 
In order to obtain water-soluble complexes of quantum dots and photosensitizer 
molecules, solubilization of nanostructures with hydrophillic ligands is usually 
performed. Covalent bonding has been demonstrated to make complexes of 
nanocrystals and tetrapyrrole molecures. It typically include two steps. Firstly, 
hydrophobic nanostructures CdSe/ZnS/TOPO are bound with cysteine.  On the second 
stage the cysteine molecules are substituted for molecules with hydroxylic end-groups 
of polyethylene glycol (PEG-OH) thiol and amino end-groups of polyethylene glycol 
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(PEG-NH2) thiol [47]. It allows creating stable colloid solutions of quantum dots.  1-
Ethyl-3-(3- dimethylaminopropyl)carbodiimide (EDAC) is used as a linking agent.  
An example of obtaining complexes formed by electrostatic interaction is variants 
with hydrophobic CdSe/ZnS/TOPO nanoparticles solubilized by 2-
(dimethylamino)ethanthiol (DMAET) molecules in order to provide a positive charge 
on the surface of QDs [47]. 
A water-soluble metal-free tetra(p-trimethylamino)phenyporphyrin (TAP), which 
is a positively charged product of tetraphenylporphyrin, is used as a photosensitizer; 
another photosensitizer example is chlorin e6 [49]. 
  
2.3.2. Photophysical properties of nanostructure-containing complexes  
 
In nanostructure complexes with tetrapyrrole molecules an alteration of the 
tetrapyrrole molecule spectral form compared to its free state is often observed [47]. 
TAP absorption spectra plotted as the difference between the spectra of 
complexes and unbound nanostructures are shown on Figure 2.8.  When TAP interacts 
with the nanostructures, the peak of its band is shifted into the red spectral region.  
23 
 
 
Figure 2.8. Absorption spectra (1) of free TAP, (2) TAP in the presence of 
quantum dots with 2.75 nm diameter in the solution, and (3) TAP in the presence of 
quantum dots with 3 nm diameter [47] 
Similarly, after adding chlorin e6 to the nanostructure solution in distilled water a 
significant change in chlorin e6 absorption spectrum is observed, as seen from Figure 
2.9. Therefore, a shift of the first absorption band and an appearance of a second 
absorption band around 500 nm are observed.  The Soret band remains almost 
unmoved, but its significant broadening is observed.  
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Figure 2.9. Absorption spectra. 1 - QD, 2 - QD-chlorin e6 complexes. Differential 
absorption spectrum of free chlorin e6 and its absorption spectrum in a QD-complex are 
shown on the inset (curves 3 and 4 respectively) [48] 
 
It is noted that adding photosensitizer into the nanostructure solution leads to a 
decrease in nanostructure luminescence intensity as well as to appearance of a 
luminescent band of the photosensitizer associated in a complex with the nanostructures 
[48]. This process is depicted on Figure 2.10. 
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Figure 2.10. Luminescence spectra. 1 and 2 – ZnS: Mn before and after mixing 
the QD solution with a solution of Ce6 (excited by 300 nm radiation); 3 – QD/Ce6 
mixed solution (excited by light with wavelength 400 nm); 4 – luminescence spectrum 
of Ce6, obtained as a result of subtracting the luminescence spectrum of QDs from the 
luminescence spectrum of the mixed QD/Ce6 solution (2).  The inset shows  
615–740 nm section of the spectrum at an enlarged scale [48]. 
 
Luminescence quenching in nanostructures as a result of their association in a 
complex with tetrapyrrole or similar molecules is considered to be one of the most 
characteristic behaviors during complexation. Some research results show how the 
chiral properties of chlorin e6 are changing in the process of binding into complex with 
semiconductor nanostructures [50]. 
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2.4 Conclusions 
 
Based on the performed analytical review, the following conclusions can be 
made: 
 A thorough approach to study photophysical properties of nanocrystals 
with different modifications and complexes based on them is required for 
successful applications of semiconductor nanostructures in different fields, 
including medicine.  
 The chirality of nanocrystals plays a tremendous role in the living objects, 
and thus it should be considered in the processes of fabricating hybrid 
nanostructures designed for studying biological samples.  
 Semiconductor nanocrystals are suitable photoexcitation energy donors in 
the FRET process in nanostructure/photosensitizer complexes, therefore 
allowing to improve the PDT efficiency.  
In this work we studied optical and photophysical properties of chiral 
nanocrystals, performed research of induced nanostructure chirality influence on their 
cellular absorption in the living cells of Ehrlich ascites carcinoma, and investigated 
chiral nanocrystals interaction with chlorin e6.  
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3 Research methods and materials 
3.1. Reagents 
 
We used chloroform as a solvent for hydrophobic nanoparticle fabrication: 
CdSe/ZnS QDs and CdSe/CdS DiRs.  Methanol was used for nanostructure purification.  
The nanostructures were solubilized by hydrophilic L- and D-cysteine molecules, 
dissolved in methanol with addition of hydrochloric acid.  
We used DMEM (Dulbecco's Modified Eagle Medium) for testing nanostructure 
stability in biological media. DMEM is a sterilized mixture of non-organic salts, amino 
acids, vitamins, glucose and phenol red in purified water.  
Distilled water and dimethyl sulfoxide (DMSO) are served as solvents for 
hydrophilic nanostructures and complexes based on them.  
The reagents were purchased from Aldrich and used without preliminary 
purification. 
Optically active levorotatory chlorin e6 purchased from Fronter Scientific, that 
did not require further purification, was used as a photosensitizer. 
 
3.2. Materials 
 
In this work we used semiconductor CdSe/ZnS core/shell quantum dots with a 
luminescence band peak centered at 530 and 580 nm, hereinafter for brevity, referred to 
as 530 QDs and 580 QDs.  Another type of nanostructures used was CdSe/CdS quantum 
dots in quantum rods synthesized using methods shown in Ref. 11 and 14 with a 
luminescence band maximum at 620 nm, hereinafter for brevity, referred to as 620 
DiRs. 
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3.3 Equipment and methods for nanostructure characterization 
 
IR spectra of the samples were recorded for providing evidence of successful 
solubilization of nanostructures by L- and D-cysteine. A Fourier transform infrared 
(FTIR) spectrometer Tensor 27 (Bruker), designed for scanning in 4000–400 cm-1 
range, was used for performing the analysis.  
Chirality of nanostructures was investigated using a circular dichroism 
spectrometer JASCO J-1500 (JASCO analytical instruments), designed for studying 
circular dichroism in a spectral range of 300-700 nm. 
The forms, sizes and size dispersions of the nanostructures were estimated using a 
scanning electron microscope (MERLIN. Carl Zeiss) with Oxford Instruments 
Nanoanalysis tools. 
Nanostructures and their complexes with chlorin e6 were studied by stationary 
optical spectroscopy methods.  The absorption and fluorescence spectra were recorded 
using a UV-3600 spectrophotometer (Shimadzu) and a Cary Eclipse spectrofluorimeter 
(Varian), respectively. 
We used laser scanning luminescent microscope MicroTime 100 (PicoQuant) for 
measuring luminescence decay times.  In this work luminescence decay of 
nanostructures was recorded using optical bandpass filters transparent in 580, 620 and 
670 nm regions for registering luminescence of QDs, DiRs and chlorin e6, respectively.  
In order to acquire luminescent images of nanostructures in cancerous cells, we 
used a laser scanning confocal microscope LSM 710 (Carl Zeiss) that is designed for 
operation in visible spectrum and allows spectral and sectional analysis of the samples.  
The sizes of quantum dots were defined using an empirical equation for CdSe 
compounds [12]  
dCdSe = (1.6122 ∙ 10
−9)λ4– (2.6575 ∙ 10−6)λ3 + (1.6242 ∙ 10−3)λ2– (0.4277)λ + 41.57, (3.1) 
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where dCdSe is the nanostructure core diameter, and λ is the wavelength 
corresponding to a position of exciton absorption band of the quantum dot. 
The thickness of ZnS shell is considered to be 5 Å [12,13]. 
The extinction coefficient was calculated as follows 
ε = 5857·(d)2.65, (3.2) 
where ε is the extinction coefficient (М-1cm-1), and d is the size of nanocrystals 
(nm). 
For calculating the DiR parameters we used an empirical equation for CdS 
compounds 
dCdS = (-6,6521∙10
-8)λ3 + (1,9557 ∙ 10-4)λ2 - (9,2352 ∙ 10-2)λ + 13,29 (3.3) 
Here, the extinction coefficient is defined as 
ε = 21536∙(d)2,3 (3.4) 
The core diameters of CdSe QDs and DiRs were approximately 3,5 and 4 nm, 
respectively. The length of a rod-shaped shell in the CdS DiRs was about 6 nm. 
Optical parameters of nanocrystals include absorption and photoluminescence 
spectra, as well as luminescence quantum yield and its decay kinetics. 
Luminescence quantum yield (φ) is calculated as a ratio between the numbers of 
emitted (Nemit) and absorbed quanta (Nabs)  
emit
abs
N
N
   
(3.5) 
Luminescence quantum yield of nanostructures is usually defined by comparative 
method that requires using a sample with the known value of luminescence quantum 
yield as a reference. Most often, rhodamine 6G with quantum yield 95% is used as 
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reference. Therefore, the following equation is used for defining the luminescence 
quantum yield of nanostructures  
𝜑 = 𝜑0 ∙
∫ 𝐼𝑠𝑎𝑚𝑑𝜆∙𝑛𝑠𝑎𝑚
2 ∙𝐷𝑟𝑒𝑓
∫ 𝐼𝑟𝑒𝑓𝑑𝜆∙𝑛𝑟𝑒𝑓
2 ∙𝐷𝑠𝑎𝑚
, 
(3.6) 
where 𝜑0 is luminescence quantum yield of the reference, ∫ 𝐼𝑠𝑎𝑚𝑑𝜆 ,  ∫ 𝐼𝑟𝑒𝑓𝑑𝜆 
are integral luminescence quantum yields of the sample and the reference, respectively, 
𝐷𝑠𝑎𝑚, 𝐷𝑟𝑒𝑓 are optical densities of the sample and the reference at the luminescence 
excitation wavelength, 𝑛𝑠𝑎𝑚, 𝑛𝑟𝑒𝑓 are refractive indices of the sample and reference 
solvents.  
Luminescence lifetime of  nanostructures fits well into a multiexponential decay 
model:  
I(t) = 𝑦0𝑛 + ∑ (𝐴𝑛 exp (−
𝑡
𝜏𝑛
))𝑛 , 
(3.7) 
where 𝐴𝑛 and 𝜏𝑛 are fluorescence amplitudes and lifetimes of nanostructures.  
Mean luminescence lifetime was calculated using the following equation 
〈𝜏〉 =
∑ 𝐴𝑛∙𝜏𝑛
2
𝑛
∑ 𝐴𝑛∙𝜏𝑛𝑛
 (3.8) 
Nanostructure preparation 
Preliminary purification of samples was performed for removing the excessive 
stabilizer molecules and impurities: 
5 mg of solid nanostructures were dissolved in 500 μl of chloroform, then 1 ml of 
methanol was added to the solution; and then it was intensely stirred and precipitated in 
a centrifuge (1 min, 15 000 rpm). The procedure was repeated 2-3 times for each 
sample.  
We used the following solubilization procedure for chiral nanostructure 
fabrication:  
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Precipitated nanostructures are dissolved in 750 μl of chloroform. The 
nanostructure solution in chloroform is kept at -20 °С for 15 min, and after that 37,5 μl 
of L-,D-cysteine solution in methanol is added until the formation of flakes in the 
nanostructure solution.  The mixture is intensely shaken, 1 ml of water and 90 μl of 
concentrated KOH solution are added. The mixture is shaken again, until approximately 
a half of the nanostructures transfers to the aqueous phase.  The fabricated aqueous 
solution of nanostructures is used for further analysis.  
The following method was used for preparing cysteine solution in methanol: 
25 mg of cysteine are dissolved in a mixed solution of methanol and hydrochloric 
acid. After complete cysteine dissolution in methanol, a concentrated solution of 
potassium hydroxide is added for neutralizing the acid.  
In case of 530 QD CdSe/ZnS solubilization, a L- and D-cysteine hydrochloride 
solution in methanol (2 mol/l) was added to a chloroform solution of CdSe/ZnS /TOPO 
(СQD ~ 5·10
-5
 mol/l). The volume of the added solution did not exceed 10% of the initial 
volume of QD solution.  The reaction mixture was shaken for 1 min, after that water 
was added. The pH value was increased to 10 by adding NaOH solution. The 
solubilized nanostructures were then transferred to the aqueous phase.  The fabricated 
aqueous solution of chiral nanostructures was used for further analysis. 
Introducing the nanostructures into EAC cells 
The Ehrlich ascites carcinoma (EAC) cell culture was obtained from the Petrov 
Research Institute of Oncology from white laboratory mice with an average weight of 
20 g after 8-9 days of ascite growth.   
The EAC cells were incubated with quantum dots in a well plate at 37 °С in a 
humidified 5% CO2 atmosphere for 3, 6, 24, 48 and 96 h in RPMI-1640 medium 
containing 10% of bovine embryonic serum and 100 U/ml of penicillin. The cell 
concentration was 4 × 106 cells per well. 
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After incubation the cells were washed 3 times and suspended in HBSS. The 
images of living cells were recorded by LSM 710 (Zeiss) laser scanning confocal 
microscope equipped with a x20/0.4 NA objective. 
Formation of nanostructure complexes with photosensitizer molecules 
In this work we performed a study of formation conditions, stability and 
photophysical properties of chiral nanostructure complexes formed in DMSO by DiRs 
and chlorin e6 (Ce6) molecules.  Samples with ratios of photosensitizer concentration to 
nanostructure concentration (n) 1:1, 2:1, 3:1, 15:1, 50:1, 100:1 were fabricated.  For 
studying the influence of Ce6 concentration on spectral properties of the obtained 
nanostructure/Ce6 complexes, microscopic amounts of Ce6 solution were gradually 
added to the nanostructure solution.  
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4 Optical properties of chiral semiconductor nanocrystals 
 
In this chapter we discuss the optical properties of two nanocrystal types: 
CdSe/ZnS quantum dots (QDs) of different sizes and CdSe/CdS quantum dots in 
quantum rods (DiRs), as well as the influence of solubilization procedure using L- and 
D-cysteine enantiomers on their spectral luminescent properties. 
 
4.1. Spectral luminescent properties of hydrophobic NCs 
 
Prior to solubilization process, investigation of spectral luminescent properties 
was conducted. Absorption and luminescence spectra of 580 CdSe/ZnS QDs in 
chloroform are shown on Figure 4.1.  
 
Figure 4.1. Absorption and luminescence spectra of 580 QDs in chloroform. 
Luminescence was excited with 450 nm light source.  
Based on the observed spectral luminescent properties, it can be seen that the 570 
nm peak corresponds to a position of the first exciton absorption band of this quantum 
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dot ensemble.  The maximum of nanocrystal luminescence is centered at 580 nm. The 
luminescence spectrum does not include any additional bands, therefore the 
luminescence origin may be attributed to exciton.  
For defining luminescence decay times of 580 QDs, we registered the decay 
curves using a luminescent microscope MicroTime 100 with a bandpass filter. Its 
maximum transmission was centered at 580 nm with 10 nm FWHM. Figure 4.2 shows 
the luminescence decay curve of 580 QDs. 
 
Figure 4.2. Luminescence decay curve for colloid solution of 580 QDs in chloroform 
We used two-exponential dependence for approximation; mean luminescence 
decay time for QDs was calculated using Equation 3.8, for 580 QDs it was about 10.46 
ns (Table 4.1). 
Absorption and luminescence spectra were measured for DiRs in the same way. 
The acquired data is presented on Figure 4.3. 
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Figure 4.3. Absorption and luminescence spectra of 620 DiRs in chloroform. 
Luminescence was excited with 450 nm light source. 
Spectral-luminescent analysis data demonstrates that the 600 nm band 
corresponds to CdSe exciton absorption band, and 460 nm peak corresponds to the CdS 
band. The maximum of nanostructure luminescence was positioned at 620 nm. No 
additional bands were observed in the luminescence spectrum, therefore luminescence 
in 620 DiRs can be of exciton origin, too.    
Luminescence decay was registered using an interference filter centered at 620 
nm (Figure 4.4). 
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Figure 4.4. Luminescence decay curve of 620 DiRs in chloroform. 
We used two-exponential dependence (Equation 3.7) for approximation. Mean 
luminescence lifetime (Equation 3.8) for hydrophobic 620 DiRs was found to be 9 ns 
(Table 4.1). 
Absorption and luminescence spectra for 530 QDs were measured using the same 
technique. The acquired data is presented on Figure 4.5. 
 
Figure 4.5. Absorption and luminescence spectra of 530 QDs in chloroform. 
Luminescence was excited with 450 nm light source. 
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Based on the observed spectral luminescent properties, one may see that the 570 
nm peak corresponds to a position of the first exciton absorption band of the quantum 
dot. The maximum of nanostructure luminescence is positioned at 530 nm. 
Luminescence decay was registered using an interference filter centered at 530 nm. 
Luminescence quenching curve is shown of Figure 4.6. 
 
Figure 4.6. Luminescence decay curve of 530 QDs in chloroform. 
We used two-exponential dependence (Equation 3.7) for approximation. Mean 
luminescence decay time (Equation 3.8) for 530 QDs was found to be 18 ns (Table 4.1). 
Table 4.1. Spectral luminescent parameters of various hydrophobic nanostructures 
NC 
Luminescence 
quantum 
yield, % 
Amplitude A1, 
% 
τ1, 
ns 
Amplitude A2, 
% 
τ2, 
ns 
<τ>, 
ns 
580 QD 1.5 50±10 1.8 50±10 11.74 10.46 
620 
DiR 
3.9 86±2 4.4 14±2 16.33 9.03 
530 QD 11.6 95±1 2.9 5±1 18.22 18.0 
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4.2. FTIR characterization of nanostructures 
 
For fabricating nanostructures with induced chirality we used phase transfer 
method from organic phase into aqueous, with the help of cysteine enantiomers, as 
described in Chapter 3.  
In order to prove successful solubilization of nanostructures with L- and D-
cysteine, infrared (IR) spectra of the nanostructures were registered. Figure 4.7 shows 
the IR spectra of capped 580 QDs, 620 DiRs and 530 QDs.   
 
Figure 4.7. Infrared absorption spectra of chiral nanostructures capped with L- and D-
cysteine 
According to studies [51] and [52], the presence of two peaks in the region 
around 1380 cm
-1
 and 1580 cm
-1
, corresponding to the symmetric stretching vibration of 
the carbonyl COO
−
 group and the asymmetric bending vibration of the NH3+ group, 
respectively, confirms that these groups in cysteine molecules are free.  Absence of the 
peak at 2550 cm
-1
 related to a thiol group –SH [53], indicates successful binding of 
cysteine with the nanostructure surface through this group. 
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4.3.  Electron microscopy characterization of nanostructures 
 
In order to get information about the forms, mean sizes and size dispersion of the 
chiral nanocrystals capped with L- and D-cysteine, the samples were investigated using 
electron microscopy methods. SEM images of 580 QD and 620 DiR nanostructures are 
shown on Figures 4.8 and 4.9. 
During phase transfer process there is a large probability of spontaneous merging, 
i.e. aggregation of nanostructures, therefore electron microscopy was used for 
controlling the condition of chiral NC aggregates as well.  
 
Figure 4.8.  SEM image of 580 QDs 
No visible nanocrystal size dispersion is observed on Figure 4.8, and the sizes (3-
4 nm in diameter) mostly correspond to estimations calculated from the position of the 
exciton absorption band using an empirical Equation 3.1 from Ref. 12.  
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Figure 4.9. SEM images of 620 DiRs 
Mean parameters of DiR nanostructures are 10 nm in length and 4 nm in 
diameter, which is in agreement with the size estimations from empirical Equations 3.1 
and 3.3. No aggregation is observed in nanostructure samples capped with cysteine 
enantiomers. 
 
4.4. Optical properties of chiral NCs 
 
Solubilization of nanocrystal surface by enantiomers of chiral molecules may 
result in inducing chirality of the former, which in turn leads to an appearance of several 
peaks in their circular dichroism spectra, corresponding to electron transition bands of 
nanostructures. Because of unequal absorption of light with different circular 
polarizations, it is necessary to measure circular dichroism spectra of L- and D-cysteine 
capped 580 QDs, 620 DiRs and 530 QDs. Circular dichroism spectra that were recorded 
simultaneously with the absorption spectra are presented on Figures 4.10, 4.11 and 4.12. 
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A 
 
B 
Figure 4.10. Circular dichroism (A) and absorption (B) spectra of 580 L- and D-cysteine 
capped QD colloid solution  
 
A 
 
B 
Figure 4.11. Circular dichroism (A) and absorption (B) spectra of 620 L- and D-cysteine 
capped DiR colloid solution 
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A 
 
B 
Figure 4.12. Circular dichroism (A) and absorption (B) spectra of 530 L- and D-cysteine 
capped QD colloid solution 
Absorption spectrum analysis of hydrophilic nanocrystals has shown that for all 
types of nanostructures phase transfer from the organic to the aqueous phase in the 
presence of L- and D-enantiomers does not lead to any significant changes in their 
absorption spectra. 
 As can be seen from Figures 4.10-4.12, the peaks situated at NC electron 
absorption bands, which have amplitudes with opposite signs for L- and D-enantiomers, 
appeared in CD spectra of all structures. Signal symmetry in the areas of circular 
dichroism spectra corresponding to exciton absorption bears evidence of successful 
solubilization of nanostructures with chiral ligands [29].  
After NC solubilization the luminescence spectra of nanostructures were 
measured, shown on Figures 4.13-4.15. Luminescence was excited with a 450 nm light 
source. 
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Figure 4.13. Luminescence spectra of L- and D-cysteine capped 580 QDs excited by 
450 nm radiation 
 
Figure 4.14. Luminescence spectra of L- and D-cysteine capped 620 DiRs excited by 
450 nm radiation 
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Figure 4.15. Luminescence spectra of L- and D-cysteine capped 530 QDs excited by 
450 nm radiation 
Analysis of spectral luminescent properties of hydrophilic NCs demonstrated that 
for all types of nanostructures a decrease of luminescence quantum yield compared to 
the hydrophobic nanostructures is observed.  Quantum yield values for all types of 
chiral structures are given in Table 4.2. 
We also studied luminescence kinetics of the chiral nanostructures, as presented 
in Figure 4.16, 4.17 and 4.18. 
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B 
 
Figure 4.16. Luminescence decay curves for L- (A) and D-cysteine capped 580 QDs 
in water 
 
 
Figure 4.17. Luminescence decay curves for L- and D-cysteine capped  
620 DiRs in water 
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Figure 4.18 Luminescence decay curves for L- (A) and D-cysteine (B) capped  
530 QDs in water 
 
The analysis of nanostructure luminescence decay curves has revealed a reduction 
in luminescence decay times for all types of nanostructures, which correlates with their 
decrease of luminescence quantum yields.  Luminescence decay time of 580 QDs 
significantly decreased to 2.16 and 2.25 ns, respectively, after solubilization with L- and 
D-cysteine. In 620 DiRs luminescence decay time decreased to 1.6 ns after 
solubilization regardless of solubilizer type.  Luminescence lifetimes of 530 QDs were 
found to be 10.5 ns for both chirality types (Table 4.2). 
Table 4.2. Spectral luminescent parameters of chiral nanostructures  
in aqueous solutions 
NC Quantum yield, % <τ>, ns 
580 QDs, L-cys 1.3 2.16 
580 QDs, D-cys 1.2 2.25 
620 DiRs, L-cys 1.6 1.6 
620 DiRs, D-cys 1.6 1.6 
530 QDs, L-cys 5 10.5 
530 QDs, D-cys 5 10.5 
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It is very likely that luminescence of all three types of nanostructures is quenched 
during thiol solubilization as a result of hole transfer from the NS to the thiol group 
[54]; it is supported by the fact that luminescence lifetimes of the nanostructures 
decrease.  The extent of luminescence quenching in the nanostructures did not depend 
of chirality type of the solubilizer. 
 
4.5. Investigation of luminescent properties of chiral NCs in biological media 
 
For investigating stability of nanostructures in biological media we chose 
nutrition media DMEM and DMEM with protein serum, because this medium is a 
suitable model of a biological object. The study of NC interaction with these media was 
conducted using 620 DiRs. We registered NC luminescence spectra in nutrition media, 
shown on Figure 4.19. 
A 
 
B 
 
Figure 4.19 Luminescence spectra of chiral 620 DiRs in DMEM medium (A) and 
DMEM medium with serum (B) excited by 450 nm light 
Our spectral-luminescent analysis has uncovered that in the DMEM nutrition 
medium a luminescence rise appears in 620 DiRs compared to the nanostructures in 
water. The rise was independent of solubilizer type; however it was higher for D-
cysteine capped 620 DiRs. During the repeated measurements after 1 hour, the 
550 600 650 700
0
250
500
750
1000
L
u
m
in
es
ce
n
ce
 i
n
te
n
si
ty
 (
a.
u
.)
Wavelength (nm)
 DMEM 620 DiR L-cys
 DMEM 620 DiR D-cys
 DMEM 1h 620 DiR L-cys
 DMEM 1h 620 DiR D-cys
550 600 650 700
0
250
500
L
u
m
in
es
ce
n
ce
 i
n
te
n
si
ty
 (
a.
u
.)
Wavelength (nm)
 DMEM+serum 620 DiR L-cys
 DMEM+serum 620 DiR D-cys
 DMEM+serum 1h 620 DiR L-cys
 DMEM+serum 1h 620 DiR D-cys
48 
 
luminescence rise of approximately 10% was observed for D-cysteine capped 
nanostructures, with no change of intensity for nanostructures with L-cysteine. 
Repeating the experiment in DMEM medium with serum led to luminescence 
quenching in the nanostructures, halving its intensity compared to luminescence in 
DMEM. Luminescence of 620 DiRs in DMEM medium with serum rose again after an 
hour, demonstrating approximately 35% intensity increase in L-cysteine capped 
nanostructures and 50% in D-cysteine capped nanostructures. It can possibly be 
explained by enantioselective interaction in the system between the medium 
components, the chiral nanostructures, and the leftovers of free solubilizer molecules. 
In order to analyze luminescence decay kinetics in the samples and to study 
spatial distribution of the luminescent particles in the sample FLIM (Fluorescence-
lifetime imaging microscopy) images were recorded in DMEM and DMEM with serum 
media within a 60 minute interval, as presented on Figure 4.20. 
 
Figure 4.20. FLIM images of chiral DiRs in DMEM medium and DMEM medium 
with serum: A-B: 620 L-cysteine capped DiRs in DMEM medium with 60 minute 
interval;  C-D: 620 L-cysteine capped DiRs in DMEM medium with serum with 60 
minute interval; E-F: 620 D-cysteine capped DiRs in DMEM medium with 60 minute 
interval; G-H: 620 D-cysteine capped DiRs in DMEM medium with serum with 60 
minute interval. 
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According to FLIM date, nanostructure aggregates can be seen in all sample types 
in the form of luminescent ensembles. Conceivably, adding the serum to the nutrition 
media leads to a decrease in nanoparticle aggregation ability, since we observed less 
luminescent ensembles. A multi-exponential luminescence decay model was used for 
determining 620 DiRs luminescence lifetime in the nutrition medium. Two-exponential 
dependence (Equation 3.7) was used for approximation, and mean luminescence decay 
times were calculated with Equation 3.8.  The approximation results are shown in Table 
4.3. 
Table 4.3. Luminescence decay times of chiral nanostructures in biological media 
NC 
Amplitude 
A1, % 
τ1, ns 
Amplitude 
A2, % 
τ2, ns <τ>, ns 
DMEM DiR L-
cysteine 
50±10 3.8 50±10 3.2 3.5 
DMEM DiR L-
cysteine 1 hour 
50±10 3.8 50±10 3.2 3.5 
DMEM DiR D-
cysteine 
50±10 3.11 40±10 5.05 4.3 
DMEM DiR D-
cysteine 1 hour 
50±10 4.4 50±10 5.32 4.9 
DMEM+serum DiR 
L-cysteine 
50±10 2.5 50±10 2.13 2.4 
DMEM+serum DiR 
L-cysteine 1 hour 
30±20 4.8 70±20 2.14 3.5 
DMEM+serum DiR 
D-cysteine 
40±10 2.31 50±10 2.12 2.2 
DMEM+serum DiR 
D-cysteine 1 hour 
50±10 4.44 50±10 2.76 3.9 
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During the processes of nanostructure incorporation into biological media, the 
luminescence decay times of 620 DiRs increased. However, using DMEM nutrition 
medium with serum resulted in a decrease in luminescence lifetimes in nanostructures 
regardless of solubilizer type.  Along with this, a temporal increase of luminescence 
lifetimes of 620 DiRs is observed regardless of the solubilizer and medium type. 
It can be assumed that introduction of the serum into the nutrition medium yet 
leads to formation of nanostructure aggregates, which are afterwards dissolved due to a 
certain form of interaction with the serum. This assumption is indirectly supported by a 
more significant (percentagewise) temporal luminescence rise in nanostructures situated 
in nutrition media with the serum: 35% for L-cysteine capped and 50% for D-cysteine 
capped 620 DiRs compared to 0% and 10%, respectively, in nutrition media without the 
serum. 
  
4.6 Conclusions 
 
The studies of chiral semiconductor nanocrystal optical properties have 
demonstrated the following: 
 Chiral nanostructures based on 580 QDs, 620 DiRs and 530 QDs were 
formed during solubilization processes of nanocrystals with L- and D-
cysteine. 
 Luminescence decay times and quantum yields of all types of 
nanostructures decrease during nanostructures solubilization with chiral L- 
and D-cysteine enantiomers, probability due to hole transfer from the 
nanostructures to the thiol group of cysteine molecules on the NC surface.  
 During the processes of nanostructure introduction into biological media, 
the luminescence decay times of 620 DiRs increased, however, using 
DMEM nutrition medium with serum resulted in a decrease in 
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luminescence decay times in 620 DiRs for all solubilizer types. A 
significant temporal increase of luminescence decay times in nutrition 
media with serum indicates the destruction of chiral nanostructure 
aggregates.  
 
52 
 
5 Enantioselective uptake of CdSe/ZnS QDs by EAC cells 
 
Below we present the results of in vitro study of chiral nanostructures optical 
properties in the living cells of Ehrlich ascites carcinoma (EAC) in mice using 530 
CdSe/ZnS QDs as an example. 
 
5.1. Investigation of chiral CdSe/ZnS QDs spectral luminescent properties in EAC 
cells 
As shown in the previous chapter, water-soluble chiral nanocrystals can be 
fabricated as a result of CdSe/ZnS nanocrystals phase transfer from the organic phase to 
the aqueous in the presence of cysteine enantiomers.  530 CdSe/ZnS QD cellular uptake 
by the living Ehrlich ascites carcinoma cells was performed using the method described 
in Chapter II. Luminescent images of EAC cells incubated with L- or D-cysteine 530 
CdSe/ZnS QDs during 3, 6, 24 or 48 hours are shown on Figure 5.1. 
 
 
Figure 5.1. Luminescent images of incubated with L,D-cysteine 530 QD nanostructure 
ensembles (A) and pictures acquired by overlapping the luminescent signals on cell 
images (B). The signals were measured after 3, 6, 24 and 48 hours of incubation, 
respectively. 
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530 QDs luminescence was excited by 405 nm light and registered in 500-560 
spectral band, corresponding to 530 QD luminescence band.  
The luminescent images in Figure 5.1 confirm cellular uptake of 530 QDs. The 
areas with significantly higher luminescence intensity than in the other cell parts 
indicate the formation of cellular bubbles – vesicles.  We observed a gradual increase of 
530 QDs luminescence intensity in the cells for both chiral forms during incubation. 
Luminescent images analysis (Figure 5.1) has shown that quantum dot luminescence 
intensity with L-cysteine was higher than with D-cysteine during all incubation periods.  
The luminescent images of chiral 530 QDs (Figure 5.2) demonstrate that the 
luminescence intensity of L-cysteine capped 530 QDs in EAC cells is significantly 
higher than that of D-cysteine capped QDs by the end of 96 hour incubation. 
 
Figure 5.2. Luminescent images of EAC cells with D- and L-enantiomer capped 530 
QDs after 96 h of incubation 
We recorded luminescence spectra of chiral 530 QDs in cells. Luminescence 
spectra and mean luminescence intensities of 530 QDs in EAC cells are depicted on 
Figure 5.3. Mean luminescence intensity values were calculated based on luminescence 
intensities of nanocrystal ensembles in several cells.  
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Figure 5.3. Spectral luminescent parameters of L- and D-cysteine capped 530 QDs:   
A: Luminescence spectra of 530 QDs in water and EAC cells after 96 hours of 
incubation; B: mean luminescence intensity of 530 QDs in the cells versus incubation 
time. 
It can be seen from Figure 5.3 that firm localization of QDs in cellular vesicles 
leads to a red shift of the QD luminescence band with respect to its position in aqueous 
solution. This may be caused by dot-to-dot energy transfer through FRET mechanism 
[55] in case of low distances between NC in cell vesicles. Luminescence intensity (I) is 
proportional to a product of quantum yield (φQD), extinction coefficient (ε) and 
concentration of nanostructures (C): 𝐼~𝜑𝑄𝐷 ∙ 𝜀 ∙ С.  Since the luminescence intensity of 
L-cysteine capped QDs in a single cell is two times higher than that of D-cysteine 
capped QDs after 96 hours of incubation, it can be caused either by concentration of the 
nanocrystals introduced into cells, or by unequal luminescence quantum yields. In order 
to answer this question, we should study the luminescence kinetics of 530 QDs in EAC 
cells. 
 
5.2. Luminescence kinetics of 530 QDs in EAC cells 
 
For studying 530 QD stability and investigating the reason for luminescence 
intensity increase of 530 QD ensembles in EAC cells, QD luminescence decay times 
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were measured. Luminescence decay curves for chiral 530 QDs in EAC cells are shown 
on Figure 5.4. Decay curves of the initial hydrophobic QDs and the QDs in water 
solution are given for reference.  
 
Figure 5.4. Luminescence decay curves of L- and D-cysteine capped 530 QDs in EAC 
cells, in water and initial 530 QDs in toluene. A bandpass filter centered at 530 nm was 
used for luminescence registration.   
We used a three-exponential function (Equation 3.7) for approximating the 
luminescence decay curves of nanostructures. 530 QDs mean luminescence decay time 
was calculated using Equation 3.8. Luminescence lifetime of L- and D-cysteine capped 
530 QDs in cells appeared to be equal for almost all incubation periods; mean 
luminescence decay times were found to be 15 ns and 16 ns, respectively. 
Luminescence quantum yield (φ) of nanocrystals is proportional to luminescence 
lifetime (τ) and energy transition radiative constant (kr) 
rk   (5.1) 
 Therefore, due to very close luminescence lifetimes and assuming the radiative 
constant to be unaltered we come to a conclusion that luminescence quantum yields of 
chiral nanocrystals in cells are almost equal.  This fact indicates the absence of 
enantioselective fluorescence quenching upon 530 QD incorporation into the cells and 
enables the use of luminescence intensity to estimate the chiral QD relative 
concentration inside the cells. It means that concentration of the incubated L-cysteine 
56 
 
capped 530 QDs is higher than the concentration of D-cysteine capped QDs, bearing 
evidence of enantioselective cellular uptake of nanocrystals in EAC cells.  
 
5.3 Conclusions: 
 We have studied luminescence intensities and decay times of chiral 530 
QDs in the living cells of Ehrlich ascites carcinoma. 
 Due to very close QD luminescence lifetimes and assuming the radiative 
constant of QDs to be unaltered we came to a conclusion that the 
luminescence intensity of 530 QDs in cells allows to determine relative QD 
concentrations in EAC cells. L-cysteine capped 530 QD concentration in 
EAC cells after 96 hours of incubation was found to be two times higher 
than of D-cysteine capped QDs. 
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6 The study of interaction between nanostructures and photosensitizer molecules  
 
As shown in the previous chapter, the chirality of CdSe/ZnS QDs may have a 
significant impact on their  living EAC cells penetration efficiency, indicating that QD 
chirality can largely affect their interaction efficiency with chiral molecules.    
Chlorin e6, used today in clinical practice as a PDT photosensitizer, is an L-
enantiomer of the chiral molecule. For this reason, it is of interest to investigate the 
influence of nanostructure chirality type, namely for L- and D-cysteine stabilized 
CdSe/ZnS DiRs, on their interaction efficiency with chlorin e6 molecules. 
 In this chapter we describe interaction of chiral nanostructures with 
photosensitizer chlorin e6 molecules in DMSO solution. In our experiments we used 
chiral 620 DiRs that were proved to be stable in biological media. 
 
6.1. Spectral luminescent properties of chiral nanostructures mixtures with 
photosensitizer molecules  
 
We investigated spectral luminescent properties of  chiral 620 DiR mixtures with 
chlorin e6 photosensitizer molecules in DMSO that allowed NC/chlorin e6 complex 
formation. The test samples were fabricated by increasing chlorin e6 concentration in L- 
and D-cysteine capped 620 DiR solutions with ratios 1:1, 2:1, 3:1, 15:1, 50:1, 100:1. 
Absorption spectra of the samples are shown on Figure 6.1. 
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A 
 
B 
 
Figure 6.1. Absorption spectra of 620 DiR / chlorin e6 mixtures with L-cysteine 
(A) and D-cysteine (B) capped nanostructures  with different concentrations (n) of 
chlorin e6 and 620 DiRs, respectively 1:1, 2:1, 3:1, 15:1, 50:1, 100:1. Solvent – 
DMSO.   
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Alteration of the first chlorin e6 absorption band Q (I) (~660 nm) is observed in 
the absorption spectra. It undergoes a 5 nm hypsochromic shift, indicating a possible 
form of free chlorin and bound into complex with 620 DiRs.  Analysis of chlorin e6 
absorption spectra in NC mixtures showed that chlorin e6 spectra in mixtures with 
different nanostructure enantiomers were identical.  It means that the chirality type of 
NCs does not affect chlorin e6 spectral form. 
The collected experimental data of chlorin e6 absorption in mixed solutions with 
L- and D-cysteine capped 620 DiRs indicates formation of 620 DiR/chlorin e6 
complexes in DMSO, presumably due to hydrogen bonding.  
The registered luminescence spectra of 620 DiR/chlorin e6 mixtures excited by 
450 nm radiation are shown on Figure 6.2.  
A 
 
B 
 
Figure 6.2. Luminescence spectra of 620 DiR/ chlorin e6 mixtures with L-cysteine (A) 
and D-cysteine (B) capped nanostructures  with different concentrations (n) of 620 DiRs 
and chlorin e6, 1:1, 2:1, 3:1, 15:1, 50:1, 100:1 respectively,  
excited by 450 nm light. 
620 DiRs luminescence rise is observed in the samples luminescence spectra 
from the first addition with concentration ratio 1:1.  It demonstrates 620 DiRs 
luminescence susceptibility to changes in the environment.  Further increase of chlorin 
e6 concentration in 620 DiRs mixed solution led to a decrease in DiR luminescence 
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intensity and an appearance of another band centered at ~ 670 nm. It can also be seen 
that increasing concentration of chlorin e6 in the mixed solution does not induce any 
change in 620 DiR luminescence band. A gradual luminescence quenching of 620 DiRs 
was observed after the first addition for both solubilizer chirality types, however in case 
of L-cysteine the luminescence quenching efficiency in nanostructures was somewhat 
higher. 
For studying spectral luminescent properties of chlorin e6/NC mixture we 
registered luminescence spectra excited by 640 nm light, when only chlorin e6 is 
excited. Absorption of 620 DiRs in this area is negligible, therefore all registered 
luminescence intensity corresponds exclusively to intrinsic absorption of chlorin e6 in 
this spectral region.  Luminescence spectra of the samples are shown on Figure 6.3. 
A  B  
Figure 6.3. Luminescence spectra of 620 DiR / chlorin e6 mixtures with  
L-cysteine (A) and D-cysteine (B) capped nanostructures  with different 
concentrations (n) of 620 DiRs and chlorin e6, 1:1, 2:1, 3:1, 15:1, 50:1, 100:1 
respectively, excited by 640 nm light. 
Starting with the first addition, a gradual proportional increase in photosensitizer 
luminescence intensity is observed for both 620 DiRs chirality types.  Spectral 
parameter analysis revealed a gradual decrease in luminescence quantum yield of 620 
DiRs and chlorin e6. 
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Figure 6.4 illustrates exponential dependence of 620 DiR relative luminescence 
intensity quenching on the components concentration ratio in the mixture (n = Cclorin 
e6/C620 DiR).  
 
Figure 6.4. Dependence of 620 DiRs relative luminescence intensity on concentration 
ratio (n = Cclorin e6/C620 DiR) in a 620 DiR mixed solution with chlorin e6.  
In our case the experimental data is approximated by an exponential function y = 
0,47·exp(-0.02·n)+0,52 for the L-cysteine system, and y = 0,5·exp(-0.01·n)+0,48 for the 
D-cysteine system. The fact that the exponential factor is ~ 0.01 indicates that a single 
Ce6 molecule weakly quenches the luminescence of a single 620 DiR.  Under the 
conditions of this experiment such situation may be observed when a large number of 
620 DiRs remain in a state free from photosensitizers.  It is also worth mentioning that 
620 DiR/chlorin e6 complexes form better, thus favoring enantioselective of the system. 
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6.2. Study of energy transfer efficiency in 620 DiR/chlorin e6 system 
 
According to Förster theory, two conditions must apply simultaneously for 
effectively transferring energy by FRET mechanism for a given donor-acceptor pair:  
1) The distance between a donor and an acceptor must not exceed the critical radius 
(R0). 
2) The acceptor absorption spectrum must overlap with the donor luminescence 
spectrum. Overlap integral of these two spectra, shown on Figure 6.5, affects the energy 
transfer efficiency. 
 
Figure 6.5. Absorption and luminescence spectra of the 620 DiR – chlorin e6 
donor-acceptor pair.  
Overlap integral of the acceptor absorption spectrum and the donor luminescence 
spectrum is calculated using the following equation: 
𝐼 =  ∫ 𝐼𝐷
𝑁(𝜈) ∙ 𝜀𝐴(𝜈) ∙ 𝜈
−4 𝑑𝜈 
(6.1) 
It is of order   (М-1cm3) for systems with both enantiomeric forms. 
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A distance between a donor and an acceptor at which the energy transfer 
efficiency by FRET mechanism is 50% can be calculated using: 
𝑅0
6 =
9000∙𝑙𝑛10∙Ф2∙𝑄𝑌0𝐷∙𝐼
128∙𝜋5∙𝑛4∙𝑁
, (6.2) 
where QY0D = 0,21 is the donor luminescence quantum yield without a quenching agent, 
N = 6,022 ·1023 mol-1 is Avogadro constant,  n = 1,47 is refractive index of DMSO, 
Ф2 = 2 3⁄  is the orientation factor, I is the overlap integral. Therefore, the critical radius 
is R0 = 4.95 nm. 
By Förster's equation, the transfer efficiency is calculated as: 
, 
(6.3) 
where RDA is the distance between a donor and an acceptor.  
The form of DiR nanostructures allows to assume two possible core positions 
with respect to the rod-shaped shell, leading to different distances between donors and 
acceptors.  
Let us consider two models of CdSe core positioning in the rod-shaped CdS shell. 
Schematic images of these 620 DiRs are shown on Figure 6.6. 
 
Figure 6.6. Schematic representation of 620 DiRs   
Chlorin e6 can attach to any point of the 620 DiR shell surface. 
Because the sizes of nanostructures are 4 nm in diameter and 10 nm in length, 
according to electron microscopy data, mean distances from the photoexcitation energy 
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donor (core) to the acceptor (photosensitizer molecule) are approximately 3.2 nm in 
case of central positioning of the CdSe core, and 5.5 nm in case of its localization at one 
of the end points. 
Therefore, theoretical values of energy transfer efficiency calculated from the 
Equation 6.3 reach 34% when the core is situated at one of the shell end points, and 
93% when the CdSe core is situated in the center. 
 It does not seem possible to determine energy transfer efficiency per one donor-
acceptor pair experimentally due to an uncertainty of CdSe cores position in the CdS 
shells and of Ce6 fraction bound into complex with NC in the mixtures.  
However it should be noted that the energy transfer efficiency in the studied 
samples can be analyzed using luminescence excitation spectra of Ce6 in mixtures with 
NC enantiomers. Luminescence excitation spectra of 620 DiRs and chlorin e6 in 
different concentrations with  registration wavelength 680 nm are shown on Figure 6.7. 
We performed normalization by the amplitude of the first chlorin e6 absorption band, 
that corresponds to normalization by luminescence quantum yield of chlorin e6 and by 
its concentration. It allowed us to directly analyze the energy transfer efficiency from 
the nanostructures to photosensitizer molecules judging by contribution of the 
nanocrystals absorption spectrum into the chlorin e6 luminescence excitation spectrum. 
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A 
 
 
 
B 
 
 
 
Figure 6.7. Luminescence excitation spectra of 620 DiR – chlorin e6 complexes 
(registration wavelength 680 nm) with chlorin e6 to 620 DiRs ratios (n) 1:1, 2:1, 3:1, 
15:1, 50:1, 100:1; free chlorin e6 excitation spectrum. 
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Comparing chlorin e6 luminescence excitation spectrum with the luminescence 
excitation spectra of chlorin e6 mixed with 620 DiRs, it can be seen that the 
luminescence excitation spectra of the chlorin e6 mixture with 620 DiRs considerably 
differ in form from the absorption spectrum of free chlorin e6.  The cause of this 
difference is the contribution of nanostructure absorption spectrum at 300-500 nm band 
to the excitation spectra of chlorin e6 mixed with 620 DiRs. It confirms the existence of 
energy transfer from chiral nanostructures to photosensitizer molecules. 
We calculated Ce6 sensitized luminescence normalized intensity using the 
luminescence excitation spectra of Ce6 mixtures with chiral NCs:  
registered intrinsic
sensitizer
intrinsic
I I
I
I

 , 
(6.4) 
 where Isensitizer is normalized sensitized luminescence intensity of chlorin e6, Iregistered is 
the registered chlorin e6 luminescence, Iintrinsic is the intrinsic luminescence of chlorin 
e6. 
The dependence of normalized Ce6 sensitized luminescence on its relative 
concentration in the mixtures with enantiomers of chiral NCs is shown on Figure 6.8. 
 
Figure 6.8. Intensity of normalized chlorin e6 sensitized luminescence associated in a 
complex with chiral 620 DiRs at different concentration ratios.   
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The sensitized luminescence (Isensitizer) is proportional to a product of chlorin e6 
luminescence quantum yield (φCe6), FRET efficiency (Et) and concentration of 
photoexcitation energy donors (CDiR), associated in a complex: 
𝐼𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑧𝑒𝑟~𝜑𝐶𝑒6 ∙ 𝐸𝑡 ∙ С𝐷𝑖𝑅, (6.5) 
Intrinsic luminescence intensity (Iintrinsic) of chlorin e6 is proportional to a product of 
chlorin e6 luminescence quantum yield (φCe6) and concentration of photoexcitation 
energy donors associated in a complex (CDiR): 
𝐼𝑖𝑛𝑡𝑟𝑖𝑛𝑠𝑖𝑐~𝜑𝐶𝑒6 ∙ С𝐷𝑖𝑅 (6.7) 
The dependences shown on Figure 5.6 demonstrate that in both chiral systems an 
increase in relative concentration (n) results in a decrease of sensitized luminescence 
intensity. In the mixture with D-cysteine capped DiRs with chlorin e6/DiRs 
concentration ratios 3:1 (n=3) chlorin e6 sensitized luminescence intensity is two times 
higher compared to chlorin in a mixed solution with L-cysteine capped DiRs. In the 
mixture with L-cysteine capped DiRs a more rapid decay dynamics of sensitized 
luminescence compared to the mixture with D-cysteine capped DiRs, indicating 
enantioselective interaction of chiral nanostructures with chlorin e6. 
The observed inequality in chlorin e6 sensitized luminescence intensity in NC 
mixtures of different chirality types with the same n can be attributed to the following: 
1. Different photoexcitation energy transfer efficiencies (FRET) for complexes 
with 1:1 stoichiometry, equal luminescence quantum yields of donors (NCs) 
and similar D-A distances in the complexes.   
2. Luminescence quantum yields of the nanostructure enantiomers differ, 
therefore leading to distinct transfer efficiencies according to Förster's theory. 
3. There is a different percentage of NC/Ce6 complexes in the samples at the 
fixed value of n. 
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It is worth noting that until today no studies of NC chirality type influence on the 
energy transfer constant in NC/molecule complexes has been performed.  However, it 
seems unlikely. It was shown in Chapter III that luminescence quantum yields of L- and 
D- DiRs are almost equal.  Thus, the most likely reason for the observed difference in 
Ce6 sensitized luminescence intensity in the mixtures with chiral NCs is, in our opinion, 
the distinct concentration of NC/Ce6 complexes with the same n; i.e. this difference 
shows enantioselective interaction of chiral NCs with chiral Ce6 molecules, as a result 
of which Ce6 is bound with the D-enantiomer of DiR more efficiently. 
   
6.3 Conclusions  
 
 In both systems an increase of n is accompanied by a decrease of sensitized 
luminescence of chlorin e6, which can be related to a decrease in 
percentage of chlorin e6 associated in a complex with chiral 620 DiRs, 
because this value is normalized on luminescence quantum yield and Ce6 
concentration for any particular n; 
 Different decay rate of sensitized luminescence directly indicates unequal 
binding efficiency of chlorin e6 with 620 DiRs of different chirality types. 
Enantioselective binding of D-cysteine capped 620 DiRs with levorotatory 
chlorin e6 photosensitizer molecules is a very likely possibility.  
 It does not seem possible to determine the percentage of chlorin e6 bound 
into complex with NC, and therefore the transfer efficiency calculated per 
single donor-acceptor pair. Further investigation is required on this matter. 
In particular, in course of such experiments it is necessary to control the 
size of nanostructures in order to eliminate the influence of aggregation on 
energy transfer efficiency from 620 DiRs to chlorin e6.  
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7 Summary 
 
In this work chiral nanostructures based on CdSe/ZnS quantum dots (QD) and 
CdSe/CdS quantum dots in quantum rods (DiR), solubilized by L- and D-cysteine were 
formed using nanocrystal phase transfer method from organic to the aqueous phase. We 
studied photophysical properties of chiral nanostructures in different biological media 
and analyzed spectral luminescent properties of complexes based on chiral 
nanostructures. 
The results of this work may be summed up as follows: 
1. Chiral nanostructures with CdSe/ZnS QDs and CdSe/CdS DiRs capped 
with L- and D-cysteine were fabricated, which was confirmed by 
registering IR absorption and circular dichroism spectra. 
2. According to electron microscopy data, the nanostructures are aggregated 
to some extent after solubilization. Aggregation is enhanced as a result of 
chiral nanostructures transfer to biological nutrition media. However, the 
nanostructures in nutrition media remain temporally stable. DMEM with 
serum was determined as the optimal culture medium. 
3. The influence of CdSe/ZnS quantum dots chirality on their cellular uptake 
was studied using the living Ehrlich ascites carcinoma cells. It was found 
that chirality affects the cellular uptake  efficiency of nanostructures. A 
comparative analysis of fluorescence intensities and lifetimes in L- and D-
cysteine capped QDs in cells has revealed enantioselective cellular uptake 
of nanostructures, namely that L-cysteine capped QDs uptake is higher 
than that of D-cysteine capped QDs. We believe this principle may lay the 
groundwork for novel approaches to studying biological objects and to 
application of nanostructures in medicine. 
4. It was found that enantioselective binding of D-cysteine capped 620 DiRs 
with levorotatory chlorin e6 photosensitizer molecules takes place during 
the formation process of chiral 620 DiR complexes with chlorin e6. 
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The results of this work, presented in Chapter IV, are published in the following 
paper: 
Martynenko I.V., Kuznetsova V.A., Litvinov I.K., Orlova A.O., Maslov V.G., 
Fedorov A.V., Dubavik A., Purcell-Milton F., Gun’ko Y.K., Baranov A.V. 
"Enantioselective cellular uptake of chiral semiconductor nanocrystals" // 
Nanotechnology - 2016, Vol. 27, No. 7, pp. 075102-(1-8) 
The results of this work, presented in Chapter V of the dissertation, are published 
in the following paper: 
Литвинов И.К., Кузнецова В.А., Орлова А.О., Исследование 
фотофизических свойств комплексов полупроводниковых квантовых стержней 
селенида кадмия и хлорина е6 // Сборник материалов IV-го Всероссийского 
конгресса молодых ученых, СПб, Университет ИТМО, 2015. 
“Litvinov I.K, Kuznetsova V.A., Orlova A.O., Investigation of photophysical 
properties of complexes formed by semiconductor cadmium selenide quantum rods and 
chlorin e6 // IV All-Russian congress of young scientists technical digest, Saint 
Petersburg, ITMO University, 2015 (in Russian).” 
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